Profitability
by Company within Biotechnology & Pharmaceuticals Industry
|
| Company |
Quarter |
Gross Margin |
Net Margin |
Cash flow Margin |
ROE |
| Agilent Technologies inc |
3 Q |
54.73% |
19.9% |
22.55% |
24.26% |
| Arca Biopharma Inc |
3 Q |
- |
- |
- |
-36.75% |
| Advanced Biomedical Technologies Inc |
2 Q |
78.89% |
-110396.11% |
-108156.11% |
- |
| Acumen Pharmaceuticals Inc |
3 Q |
- |
- |
- |
14.86% |
| Achilles Therapeutics Plc |
4 Q |
- |
- |
- |
-21.1% |
| Achieve Life Sciences Inc |
3 Q |
- |
- |
- |
-240.36% |
| Arcellx Inc |
1 Q |
- |
- |
- |
- |
| Acorda Therapeutics inc |
3 Q |
67.16% |
-41.34% |
-6.9% |
-95.51% |
| Adaptimmune Therapeutics Plc |
3 Q |
- |
-565.01% |
-256.6% |
-116.62% |
| Adma Biologics Inc |
3 Q |
23.5% |
-36.26% |
-42.61% |
-58.25% |
| Edoc Acquisition Corp |
4 Q |
- |
-586.26% |
5.76% |
- |
| Adverum Biotechnologies Inc |
3 Q |
- |
- |
- |
-59.42% |
| Aerie Pharmaceuticals Inc |
3 Q |
80.82% |
-74.25% |
40.55% |
- |
| Agenus Inc |
3 Q |
98.65% |
-249.06% |
- |
-1159.04% |
| Applied Genetic Technologies Corporation |
3 Q |
- |
- |
- |
-192.9% |
| Allied Healthcare Products inc |
2 Q |
7.39% |
-32.18% |
76.74% |
-70.44% |
| Akoya Biosciences Inc |
3 Q |
57.86% |
-94.8% |
26.28% |
-70.52% |
| Alector Inc |
3 Q |
- |
-310.72% |
80.57% |
-49.19% |
| Align Technology inc |
3 Q |
69.54% |
8.17% |
18.71% |
14.01% |
| Aligos Therapeutics Inc |
3 Q |
- |
-453.51% |
- |
-75.01% |
| Allogene Therapeutics Inc |
3 Q |
- |
-169689.8% |
-44253.06% |
-37.74% |
| Allena Pharmaceuticals Inc. |
2 Q |
- |
- |
- |
-287.46% |
| Allovir Inc |
3 Q |
- |
- |
- |
-91.04% |
| Ambrx Biopharma Inc |
4 Q |
- |
-916% |
- |
-35.95% |
| Amgen Inc |
3 Q |
- |
- |
- |
199.74% |
| Alpha Pro Tech Ltd |
3 Q |
32.73% |
7.91% |
1.19% |
12.12% |
| Aptose Biosciences Inc |
3 Q |
- |
- |
- |
-92.87% |
| Armata Pharmaceuticals Inc |
3 Q |
- |
-643.8% |
-866.67% |
-70.29% |
| Arya Sciences Acquisition Corp Iv |
3 Q |
- |
- |
- |
- |
| Aslan Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
-55.13% |
| Astrotech Corp |
3 Q |
15.79% |
-6657.89% |
-21526.32% |
-16.29% |
| Athira Pharma Inc |
3 Q |
- |
- |
- |
-28.08% |
| Atara Biotherapeutics Inc |
3 Q |
- |
-1885.87% |
-125.01% |
-104.2% |
| Aura Biosciences Inc |
3 Q |
- |
- |
- |
-24.83% |
| Autolus Therapeutics Plc |
4 Q |
- |
-17265.61% |
- |
-45.35% |
| Applied Uv Inc. |
2 Q |
22.07% |
-6.13% |
-74.09% |
-2.39% |
| Avanos Medical Inc |
3 Q |
54.48% |
7.77% |
5.2% |
1.71% |
| Avrobio Inc |
3 Q |
- |
- |
- |
-82.47% |
| Avantor Inc |
3 Q |
35.05% |
9% |
1.44% |
14.51% |
| Anavex Life Sciences Corp |
3 Q |
- |
- |
-183.91% |
-2.97% |
| Aspira Women s Health Inc |
3 Q |
55.79% |
-219.98% |
- |
-160.74% |
| Axcella Health Inc |
3 Q |
- |
- |
- |
-567.25% |
| Acuity Brands Inc |
4 Q |
41.74% |
7.51% |
6.1% |
18.95% |
| Ayala Pharmaceuticals Inc |
3 Q |
0% |
-11195.6% |
- |
-182.13% |
| Aziyo Biologics inc |
3 Q |
40.75% |
-79.99% |
-67.88% |
-1819.23% |
| Azz Inc |
4 Q |
19.58% |
-5.5% |
-2.96% |
-6.74% |
| Bioatla Inc |
3 Q |
- |
- |
- |
-57.78% |
| Biocardia Inc |
3 Q |
- |
-1441.98% |
-918.4% |
-172.74% |
| Brainstorm Cell Therapeutics inc |
3 Q |
- |
- |
- |
-236.36% |
| Biocryst Pharmaceuticals Inc |
3 Q |
95.33% |
-56.08% |
-33.86% |
- |
| Black Diamond Therapeutics Inc |
3 Q |
- |
- |
- |
-58.68% |
| Beam Therapeutics Inc |
3 Q |
- |
-693.56% |
-690.6% |
-39.8% |
| Biogen Inc |
3 Q |
81.28% |
45.24% |
43.11% |
20.44% |
| Bionovate Technologies Corp |
3 Q |
- |
- |
- |
- |
| Bio rad Laboratories Inc |
3 Q |
54.9% |
-24.12% |
-11.55% |
-58.55% |
| Berkeley Lights Inc |
3 Q |
70.22% |
-100.79% |
-104.61% |
-47.12% |
| Bluebird Bio Inc |
3 Q |
- |
-107774.65% |
- |
-194.95% |
| Biomerica Inc |
4 Q |
23.74% |
-109.73% |
-68.05% |
-66.11% |
| Bionano Genomics Inc |
3 Q |
25.05% |
-440.51% |
13.95% |
-38.48% |
| Bionik Laboratories Corp |
3 Q |
61.2% |
-232.29% |
-191.49% |
-190.66% |
| Biontech Se |
4 Q |
- |
- |
- |
86.54% |
| Bruker Corporation |
3 Q |
52.48% |
13.84% |
-15.18% |
27.29% |
| Biondvax Pharmaceuticals Ltd |
4 Q |
- |
- |
- |
-18.48% |
| Burzynski Research Institute Inc |
4 Q |
- |
- |
- |
- |
| Cabaletta Bio Inc |
3 Q |
- |
- |
- |
-53.52% |
| Candel Therapeutics Inc |
3 Q |
- |
-28025.81% |
-30964.52% |
32.54% |
| Trees Corporation |
3 Q |
35.9% |
-85.12% |
30.88% |
-125.72% |
| Capstone Companies Inc |
3 Q |
23.51% |
-1059.13% |
-1291.54% |
-125.47% |
| Casi Pharmaceuticals inc |
3 Q |
58.42% |
-49.18% |
- |
-36.52% |
| Cannabis Global Inc. |
2 Q |
1.47% |
-59.89% |
-44.25% |
-66.53% |
| C4 Therapeutics Inc |
3 Q |
- |
-473.17% |
-114.67% |
-30.11% |
| Chase Corporation |
4 Q |
34.88% |
6.53% |
-252.3% |
11.37% |
| Codiak Biosciences Inc |
3 Q |
- |
-3693.1% |
- |
-37.62% |
| Cardio Diagnostics Holdings Inc |
3 Q |
- |
- |
-14201.73% |
0% |
| Cadre Holdings inc |
3 Q |
39.21% |
4.43% |
6.71% |
- |
| Cidara Therapeutics Inc |
3 Q |
- |
- |
- |
-498.1% |
| Creative Medical Technology Holdings Inc |
3 Q |
70.91% |
-1786.07% |
-10717.45% |
-48.26% |
| Cen Biotech Inc |
3 Q |
- |
-264.15% |
-94.3% |
- |
| Central Garden and Pet Co |
4 Q |
27.36% |
-1.41% |
-14.28% |
10.15% |
| Conformis inc |
3 Q |
35.24% |
-110.29% |
-94.75% |
-78.14% |
| Compugen Ltd |
4 Q |
88.67% |
-570.05% |
11.73% |
-32.06% |
| Cognition Therapeutics inc |
3 Q |
- |
- |
- |
-28.61% |
| Coherus Biosciences inc |
3 Q |
22.43% |
-190.76% |
24.92% |
- |
| Celldex Therapeutics inc |
3 Q |
- |
-6580.84% |
-2412.29% |
-27.74% |
| Collplant Biotechnologies Ltd |
4 Q |
87.18% |
1.52% |
62.05% |
0.53% |
| Cellectis S a |
4 Q |
45.26% |
-218.36% |
- |
-52.91% |
| Checkmate Pharmaceuticals Inc |
1 Q |
- |
- |
- |
-83.92% |
| Compass Therapeutics Inc |
3 Q |
- |
- |
- |
-31.38% |
| Cnbx Pharmaceuticals Inc |
4 Q |
- |
- |
- |
- |
| Coeptis Therapeutics Holdings Inc |
3 Q |
- |
- |
- |
- |
| Coherent Corp |
3 Q |
32.99% |
-2.88% |
0% |
2.4% |
| Caribou Biosciences Inc |
3 Q |
- |
-806.75% |
-910.11% |
-10.38% |
| Cardiff Oncology inc |
3 Q |
- |
-1555.54% |
-242.29% |
-27.78% |
| Curis Inc |
3 Q |
- |
-470.58% |
-147.15% |
-82.91% |
| Crispr Therapeutics Ag |
3 Q |
- |
-185690.43% |
-2917.02% |
-31.34% |
| Clarus Therapeutics Holdings Inc. |
2 Q |
71.36% |
-264.05% |
- |
- |
| Champions Oncology Inc |
3 Q |
47.88% |
-0.11% |
19.38% |
1.18% |
| Cytek Biosciences Inc |
3 Q |
66.36% |
4.21% |
-20.68% |
-0.9% |
| Cel sci Corporation |
3 Q |
- |
- |
- |
-89.93% |
| Cv Sciences Inc |
3 Q |
41.64% |
-27.49% |
0.67% |
-580.24% |
| Ladrx Corporation |
3 Q |
- |
- |
- |
-447.39% |
| Dbv Technologies S a |
3 Q |
- |
-833.51% |
-1702.07% |
-44.34% |
| Ginkgo Bioworks Holdings Inc |
3 Q |
95.99% |
-1007.64% |
-113.44% |
-230.47% |
| Telesis Bio Inc |
3 Q |
54.82% |
-184.48% |
39.46% |
-29.72% |
| Denali Therapeutics Inc |
3 Q |
- |
-0.05% |
-69.5% |
22.01% |
| Precision Biosciences Inc |
3 Q |
- |
-325.22% |
- |
-121.11% |
| Dyadic International Inc |
3 Q |
31.46% |
-205.68% |
-311.2% |
-61.17% |
| Eargo Inc |
3 Q |
24.04% |
-640.2% |
-234.64% |
-973.79% |
| Editas Medicine inc |
3 Q |
- |
-132680.95% |
- |
-41.33% |
| Educational Development Corporation |
4 Q |
63.52% |
0% |
-0.59% |
-0.56% |
| Energy Focus Inc |
3 Q |
-9.24% |
-150.91% |
-40.42% |
-246.71% |
| Eiger Biopharmaceuticals Inc |
3 Q |
69.41% |
-673.73% |
-255.07% |
-106.48% |
| Elevation Oncology inc |
3 Q |
- |
- |
- |
-53.82% |
| Eloxx Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-863.78% |
| Enovis Corp |
3 Q |
56.23% |
-17.32% |
-10.59% |
0.65% |
| Entera Bio Ltd |
3 Q |
25% |
- |
-335937.5% |
- |
| Enzon Pharmaceuticals inc |
3 Q |
- |
- |
- |
-20.14% |
| Erytech Pharma S.a. |
4 Q |
- |
- |
- |
-235.49% |
| Scientific Industries Inc |
3 Q |
50.53% |
-48.39% |
-19.98% |
-22.24% |
| Establishment Labs Holdings Inc |
3 Q |
68.09% |
-48.65% |
-67.75% |
-261.6% |
| Evaxion Biotech A |
4 Q |
- |
- |
- |
-75.63% |
| Edwards Lifesciences Corporation |
3 Q |
80.76% |
26.04% |
3.7% |
24.47% |
| Exscientia Plc |
4 Q |
- |
- |
- |
0% |
| Exelixis Inc |
3 Q |
96.28% |
40.14% |
9.49% |
34.7% |
| Eyepoint Pharmaceuticals Inc |
3 Q |
- |
-183.98% |
-67.64% |
-48.98% |
| Fate Therapeutics Inc |
3 Q |
- |
-557.79% |
- |
-48.78% |
| 4d Molecular Therapeutics Inc |
3 Q |
- |
-5138.2% |
-1037.2% |
-36.94% |
| Fennec Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-214.78% |
| Homology Medicines Inc |
3 Q |
- |
-4205.24% |
-16586.78% |
-1.94% |
| Forma Therapeutics Holdings Inc. |
2 Q |
- |
- |
- |
-39.68% |
| Finch Therapeutics Group Inc |
3 Q |
- |
-29254.35% |
-14044.2% |
-64.47% |
| Freeline Therapeutics Holdings Plc |
4 Q |
- |
- |
- |
-116.56% |
| Fresh Tracks Therapeutics Inc |
3 Q |
- |
-1238.27% |
-664.61% |
-133.55% |
| Fusion Pharmaceuticals Inc |
3 Q |
- |
-14465.66% |
- |
-38.72% |
| Gilead Sciences Inc |
3 Q |
80.19% |
25.36% |
-0.57% |
16.09% |
| Monte Rosa Therapeutics Inc |
3 Q |
- |
- |
- |
-12.47% |
| Gamida Cell Ltd |
3 Q |
- |
- |
- |
0% |
| Genocea Biosciences Inc |
1 Q |
- |
-5917.78% |
-6300.37% |
-182.88% |
| Genfit S a |
4 Q |
- |
78.59% |
- |
56.47% |
| Genenta Science S p a |
4 Q |
- |
- |
- |
-14.23% |
| Green Planet Bioengineering Co Ltd |
3 Q |
- |
- |
- |
- |
| Greenlight Biosciences Holdings Pbc |
3 Q |
- |
-2203.12% |
- |
-368.54% |
| Gritstone Bio Inc |
3 Q |
- |
-991.92% |
- |
-67% |
| Genethera Inc |
4 Q |
- |
- |
- |
- |
| Halozyme Therapeutics Inc |
3 Q |
77.36% |
29.49% |
26.91% |
95.77% |
| Harvard Bioscience Inc |
3 Q |
45.21% |
-12.65% |
3.29% |
-8.91% |
| Health Discovery Corporation |
3 Q |
- |
- |
- |
- |
| Cue Health Inc |
3 Q |
27.29% |
-95.28% |
-84.02% |
-14.14% |
| Hillevax Inc |
3 Q |
- |
- |
- |
- |
| Heart Test Laboratories Inc |
3 Q |
- |
- |
- |
- |
| Heska Corporation |
3 Q |
43.71% |
-0.71% |
83.99% |
-3.97% |
| Htg Molecular Diagnostics Inc |
3 Q |
46.37% |
-361.04% |
-203.39% |
-310.66% |
| Humacyte Inc |
3 Q |
- |
- |
- |
-7.01% |
| Hydrofarm Holdings Group Inc |
3 Q |
7.91% |
-31.74% |
-14.77% |
-51.15% |
| Immunitybio inc |
3 Q |
- |
-94204.24% |
- |
- |
| Immucell Corp |
1 Q |
51.72% |
8.56% |
27.2% |
2.69% |
| Icosavax Inc |
3 Q |
- |
- |
- |
-10.02% |
| Idera Pharmaceuticals Inc |
3 Q |
- |
-6324.49% |
- |
-48.24% |
| Idexx Laboratories Inc |
3 Q |
60.19% |
21.5% |
-1.8% |
118.38% |
| Ikena Oncology Inc |
3 Q |
- |
-270.82% |
- |
-28.27% |
| Inhibikase Therapeutics Inc |
3 Q |
- |
-61645.36% |
-362506.62% |
-59.24% |
| Illumina Inc |
4 Q |
64.3% |
-342.24% |
-31.03% |
-38.52% |
| Immunovant Inc |
4 Q |
- |
- |
- |
-46.3% |
| In8bio Inc |
3 Q |
- |
- |
- |
-42.68% |
| Inhibrx Inc. |
2 Q |
- |
-5306.89% |
- |
-430.07% |
| Inogen Inc |
3 Q |
40.61% |
-9.02% |
-13.27% |
-13.94% |
| Mink Therapeutics Inc |
3 Q |
- |
- |
- |
-38.71% |
| Inmune Bio Inc |
3 Q |
- |
-7882.65% |
-3885.71% |
-43.02% |
| Iovance Biotherapeutics inc |
3 Q |
- |
- |
- |
-76.45% |
| Innate Pharma Sa |
4 Q |
- |
-213.78% |
- |
-49.15% |
| Century Therapeutics inc |
3 Q |
- |
-1382.6% |
-64.61% |
-20.66% |
| Isoplexis Corporation |
3 Q |
50.79% |
-415.28% |
- |
-49.96% |
| Intuitive Surgical Inc |
3 Q |
67.55% |
20.85% |
0.18% |
11.64% |
| Iteos Therapeutics Inc |
3 Q |
- |
5.09% |
-203.63% |
42.61% |
| Invacare Corporation |
3 Q |
18.41% |
-20.16% |
0.9% |
-49.37% |
| Invivyd Inc |
3 Q |
- |
- |
- |
-20.27% |
| Jounce Therapeutics inc |
3 Q |
- |
- |
- |
-0.01% |
| Jasper Therapeutics Inc |
3 Q |
- |
- |
- |
-28.68% |
| Kaleido Biosciences Inc |
4 Q |
- |
-17742.11% |
-29390.35% |
-227.69% |
| Kodiak Sciences Inc |
3 Q |
- |
- |
- |
-62.79% |
| Kiromic Biopharma Inc |
3 Q |
- |
- |
- |
-257.83% |
| Krystal Biotech Inc |
3 Q |
- |
- |
- |
-23.14% |
| Kymera Therapeutics Inc |
3 Q |
- |
-450.24% |
- |
-32.59% |
| Standard Biotools Inc |
3 Q |
45.06% |
-114.74% |
-55.22% |
-4329.61% |
| Lakeland Industries Inc |
3 Q |
43.34% |
5.04% |
40.48% |
-4.1% |
| Lifeloc Technologies Inc |
3 Q |
37.79% |
-4.28% |
-6.24% |
-8.99% |
| Lineage Cell Therapeutics Inc |
3 Q |
92.16% |
-204% |
-1536.49% |
-58.7% |
| Logicmark Inc |
3 Q |
61.94% |
-76.08% |
-65.98% |
-40.55% |
| Lucira Health Inc |
3 Q |
-289.49% |
-368.89% |
-102.31% |
-89.63% |
| Atyr Pharma Inc |
3 Q |
- |
- |
- |
-50.01% |
| Lixte Biotechnology Holdings Inc. |
2 Q |
- |
- |
- |
-120.87% |
| La Jolla Pharmaceutical Company |
2 Q |
83.96% |
23.31% |
39.54% |
- |
| Lazuriton Nano Biotechnology u s a Inc |
2 Q |
- |
- |
- |
- |
| Lantheus Holdings Inc |
3 Q |
61.61% |
25.59% |
35.64% |
19.59% |
| Logicbio Therapeutics Inc |
3 Q |
- |
-212.55% |
-296.87% |
-115.29% |
| U s Lighting Group Inc |
3 Q |
-2.33% |
-128.49% |
-10.47% |
- |
| Lsi Industries Inc |
3 Q |
27.34% |
4.93% |
5.17% |
12.46% |
| Microbot Medical Inc |
3 Q |
- |
- |
- |
-116.84% |
| Mesoblast Ltd |
2 Q |
- |
-894.33% |
- |
-15.71% |
| Meiragtx Holdings Plc |
3 Q |
- |
-774.17% |
- |
-86.19% |
| Miromatrix Medical Inc |
4 Q |
- |
- |
- |
- |
| Milestone Scientific Inc |
3 Q |
65.57% |
-89.61% |
-51.79% |
-57.8% |
| Molecular Partners Ag |
4 Q |
- |
-653.94% |
- |
-59.45% |
| Moderna Inc |
3 Q |
67.3% |
31% |
4.64% |
70.03% |
| Msa Safety Inc |
3 Q |
44.38% |
11.76% |
6.74% |
8.19% |
| Mettler Toledo International Inc |
3 Q |
59.31% |
22.38% |
1.29% |
1856.62% |
| Myriad Genetics Inc |
3 Q |
67.77% |
-22.44% |
3.52% |
-8.18% |
| Mymd Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-83.89% |
| Mymetics Corporation |
3 Q |
- |
-1034.62% |
39.23% |
- |
| Myomo Inc |
3 Q |
66.45% |
-71.31% |
-70.96% |
-102.71% |
| Nanovation Microtech Inc |
2 Q |
- |
- |
- |
- |
| Nanovibronix Inc |
3 Q |
82.47% |
-1029.9% |
-2032.99% |
-126.29% |
| Nautilus Biotechnology Inc |
3 Q |
- |
- |
- |
-5.61% |
| Neurocrine Biosciences Inc |
3 Q |
98.43% |
17.66% |
12.61% |
5.98% |
| Neogen Corporation |
4 Q |
48.92% |
-18.19% |
-3.09% |
-1.13% |
| Natural Health Trends Corp |
3 Q |
73.56% |
0.4% |
-42.5% |
0.64% |
| Neoleukin Therapeutics Inc |
3 Q |
- |
- |
- |
-35.68% |
| Nanostring Technologies Inc |
3 Q |
53.55% |
-124.2% |
-30.32% |
-111.76% |
| Intellia Therapeutics Inc |
3 Q |
- |
-853.53% |
-234.74% |
-47.79% |
| Nutriband Inc |
3 Q |
43.48% |
-174.03% |
-85.48% |
-38.44% |
| Livento Group Inc |
3 Q |
11.74% |
-27.57% |
-76.48% |
-401.3% |
| Novavax inc |
3 Q |
40.84% |
-22.95% |
-12.86% |
- |
| Nexien Biopharma Inc |
3 Q |
- |
- |
- |
- |
| Ortho Clinical Diagnostics Holdings Plc |
1 Q |
50.11% |
2.96% |
-5.72% |
13.26% |
| Ocugen Inc |
3 Q |
- |
- |
- |
-74.32% |
| Oncocyte Corporation |
3 Q |
-2863.41% |
-23304.88% |
-31178.05% |
-90.73% |
| Orion Energy Systems Inc |
3 Q |
25.26% |
-13.27% |
17.63% |
-8.24% |
| Olink Holding Ab publ |
4 Q |
61.29% |
-40.37% |
0% |
-8.06% |
| Omega Therapeutics Inc |
3 Q |
- |
-4335.97% |
-2393.78% |
-22.55% |
| Singular Genomics Systems Inc |
3 Q |
- |
- |
- |
-4.78% |
| Organovo Holdings Inc |
3 Q |
- |
-4312.99% |
- |
-41.86% |
| Opthea Limited |
2 Q |
- |
-66087.32% |
- |
-33.52% |
| Orchard Therapeutics Plc |
3 Q |
71.53% |
-823.35% |
- |
-109.29% |
| Outlook Therapeutics Inc |
3 Q |
- |
- |
- |
-232.57% |
| Oyster Point Pharma Inc |
3 Q |
75.89% |
-657.25% |
-646.34% |
-652.98% |
| Pacific Biosciences Of California Inc |
3 Q |
41.93% |
-238.22% |
- |
-42.23% |
| Palisade Bio Inc |
3 Q |
- |
- |
- |
-114.49% |
| Passage Bio inc |
3 Q |
- |
- |
- |
-67.18% |
| Pressure Biosciences Inc |
3 Q |
12.38% |
-3098.09% |
75.89% |
- |
| Vaxcyte Inc |
3 Q |
- |
- |
- |
-50.83% |
| Biomx Inc |
3 Q |
- |
- |
- |
89.58% |
| Peak Bio Inc |
3 Q |
- |
- |
- |
- |
| Perkinelmer Inc |
4 Q |
57.18% |
11.99% |
-58.97% |
10.22% |
| Pulse biosciences inc |
3 Q |
- |
- |
- |
-300.73% |
| Pluri Inc |
3 Q |
- |
-7205.75% |
-1588.51% |
-104.15% |
| Protalix Biotherapeutics inc |
3 Q |
50.12% |
-25.15% |
-12.49% |
- |
| Pharmacyte Biotech Inc |
3 Q |
- |
- |
- |
-6.49% |
| Predictive Oncology Inc |
3 Q |
76.27% |
-890.58% |
-626.49% |
-72.78% |
| Prime Medicine Inc |
3 Q |
- |
- |
- |
- |
| Precipio inc |
3 Q |
19.68% |
-143.25% |
-105.15% |
-56.48% |
| Poseida Therapeutics Inc |
3 Q |
- |
60.54% |
-16.06% |
-18.27% |
| Polarityte Inc |
3 Q |
- |
- |
- |
-85.41% |
| Mosaic Immunoengineering Inc |
3 Q |
- |
- |
- |
- |
| Pactiv Evergreen Inc |
3 Q |
14.42% |
10.94% |
19.33% |
-9.99% |
| Quidelortho Corp |
4 Q |
51.99% |
2.45% |
- |
22.33% |
| Qiagen N v |
4 Q |
48.6% |
17.17% |
9.46% |
16.55% |
| Quince Therapeutics Inc |
3 Q |
- |
- |
- |
-60.28% |
| Quest Patent Research Corp |
3 Q |
46.4% |
37.7% |
-55.34% |
- |
| Qrons Inc |
3 Q |
- |
- |
- |
- |
| Quotient Limited |
3 Q |
-138.45% |
-518.59% |
-333.43% |
- |
| Quanterix Corp |
1 Q |
60.09% |
-37.13% |
- |
-12.04% |
| Vicarious Surgical Inc |
3 Q |
- |
- |
- |
91.41% |
| Renovacor Inc |
3 Q |
- |
- |
- |
-7.46% |
| Replimune Group Inc |
3 Q |
- |
- |
- |
-35.72% |
| Reynolds Consumer Products Inc |
3 Q |
18.41% |
4.96% |
-7.03% |
14.43% |
| Repligen Corp |
3 Q |
56.9% |
20.13% |
3.64% |
9.3% |
| Regenxbio Inc |
3 Q |
50.61% |
-284.72% |
-10.67% |
11.12% |
| Relay Therapeutics Inc |
3 Q |
- |
-24468.6% |
- |
-35.62% |
| Rapid Micro Biosystems Inc |
3 Q |
-18.74% |
-0.15% |
-504.07% |
4.38% |
| Rubius Therapeutics Inc |
3 Q |
- |
- |
- |
-192.61% |
| Revolution Medicines Inc |
3 Q |
- |
-2185.01% |
- |
-41.97% |
| Rewalk Robotics Ltd |
3 Q |
24.94% |
-616.25% |
-540.74% |
-21.55% |
| Recursion Pharmaceuticals Inc |
3 Q |
-17.09% |
-459.31% |
5.93% |
-53.04% |
| Sab Biotherapeutics Inc |
3 Q |
- |
-197.12% |
-230.78% |
-22.59% |
| Sana Biotechnology Inc |
3 Q |
- |
- |
- |
-45.49% |
| Seer Inc |
3 Q |
49.18% |
-606.32% |
- |
-18.8% |
| Seagen Inc |
3 Q |
78.81% |
-37.39% |
-1.26% |
-21.55% |
| Sangamo Therapeutics Inc |
3 Q |
- |
-200.89% |
- |
-53.18% |
| Skyx Platforms Corp |
3 Q |
30.88% |
-66136.82% |
-129885.04% |
- |
| Solid Biosciences Inc |
3 Q |
- |
- |
- |
-51.16% |
| Sanara Medtech Inc |
3 Q |
82.92% |
-10.82% |
-18.35% |
-27.49% |
| Senstar Technologies Ltd |
4 Q |
62.95% |
36.75% |
-2.72% |
35.89% |
| Senti Biosciences Inc |
3 Q |
- |
-942.24% |
0% |
-45.62% |
| Sophia Genetics Sa |
4 Q |
62.35% |
-182.14% |
- |
-26.75% |
| Spk Acquisition Corp |
3 Q |
-55.59% |
-77.82% |
-8.14% |
- |
| Seqll Inc |
3 Q |
- |
- |
- |
-32.44% |
| Sqz Biotechnologies Company |
3 Q |
- |
0% |
-617.67% |
-71.3% |
| Surgalign Holdings Inc |
3 Q |
72.81% |
-48.73% |
- |
-612.25% |
| Sorrento Therapeutics Inc |
3 Q |
58.14% |
-520.83% |
-203.45% |
-347.54% |
| Scholar Rock Holding Corp |
3 Q |
- |
- |
- |
-54.3% |
| Surrozen Inc |
3 Q |
- |
- |
- |
-75.92% |
| Steris Plc |
3 Q |
44.34% |
-26.26% |
-4.84% |
-0.15% |
| Sutro Biopharma Inc |
3 Q |
- |
-77.5% |
70.24% |
-53.85% |
| Surface Oncology Inc |
3 Q |
- |
- |
- |
-52.58% |
| Springworks Therapeutics Inc. |
2 Q |
- |
- |
- |
-38.19% |
| Talaris Therapeutics Inc |
3 Q |
- |
- |
- |
-31.84% |
| Protara Therapeutics Inc |
3 Q |
- |
- |
- |
-24.86% |
| Tarsus Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-34.24% |
| Tc Biopharm holdings Plc |
4 Q |
- |
-686.12% |
0% |
- |
| Tracon Pharmaceuticals inc |
3 Q |
- |
- |
- |
-910.69% |
| Tcr2 Therapeutics Inc |
3 Q |
- |
- |
- |
-49.52% |
| Tscan Therapeutics Inc |
3 Q |
- |
-483.05% |
- |
-15.13% |
| Bio techne Corp |
3 Q |
66.6% |
33.28% |
-2.71% |
16.53% |
| Alpha Teknova Inc |
3 Q |
44.61% |
-210.19% |
-139.16% |
-21.75% |
| Talis Biomedical Corporation |
3 Q |
-55.28% |
-3268.97% |
-2712.31% |
-59.9% |
| Tenaya Therapeutics Inc |
3 Q |
- |
- |
- |
-44.57% |
| Trinity Biotech Plc |
4 Q |
40.96% |
1% |
-0.18% |
- |
| Taysha Gene Therapies Inc |
3 Q |
- |
- |
- |
-338.37% |
| Titan Pharmaceuticals inc |
3 Q |
- |
-2776.84% |
-1971.58% |
-217.57% |
| 10x Genomics Inc |
3 Q |
76.82% |
-31.98% |
-59.94% |
-14.21% |
| United Health Products Inc |
3 Q |
50.28% |
- |
- |
- |
| Valneva Se |
4 Q |
46.01% |
-21.09% |
99.6% |
-43.04% |
| Avricore Health Inc |
4 Q |
24.85% |
-1390.9% |
- |
-77.75% |
| Vericel Corporation |
3 Q |
65.45% |
-17.06% |
7.72% |
-10.41% |
| Vickers Vantage Corp I |
3 Q |
- |
- |
- |
- |
| Vectivbio Holding Ag |
4 Q |
- |
- |
- |
-75.01% |
| Vigil Neuroscience Inc |
3 Q |
- |
- |
- |
- |
| Vir Biotechnology Inc |
3 Q |
94.06% |
46.81% |
-144.9% |
60.66% |
| Meridian Bioscience Inc. |
2 Q |
54.19% |
-10.83% |
10.33% |
12.28% |
| Volitionrx Limited |
3 Q |
- |
-23668.66% |
-960.97% |
-350.47% |
| Vor Biopharma Inc |
3 Q |
- |
- |
- |
-46.44% |
| Vaxart Inc |
3 Q |
- |
- |
- |
-67.56% |
| Voyager Therapeutics Inc |
3 Q |
- |
42.9% |
45.1% |
-21.97% |
| Windtree Therapeutics Inc |
3 Q |
- |
- |
- |
-150.46% |
| X4 Pharmaceuticals Inc |
3 Q |
- |
- |
- |
-200.38% |
| Acceleron Pharma inc |
3 Q |
- |
-206.04% |
0.16% |
-32.39% |
| Xtant Medical Holdings Inc |
3 Q |
54.6% |
-16.27% |
5.23% |
-28.27% |
| Zimmer Biomet Holdings Inc |
3 Q |
70.76% |
11.63% |
9.52% |
2.27% |
| Zivo Bioscience Inc |
3 Q |
- |
- |
- |
-253.77% |
